BCR Ligation Induces Receptor Editing in IgM+IgD− Bone Marrow B Cells In Vitro  by Hertz, Marc & Nemazee, David
Immunity, Vol. 6, 429±436, April, 1997, Copyright 1997 by Cell Press
BCR Ligation Induces Receptor Editing
in IgM1IgD2 Bone Marrow B Cells In Vitro
Marc Hertz and David Nemazee 1996), a concept in accord with the paradigm of the``clo-
nal selection'' hypothesis (reviewed by Klinman, 1996),Division of Basic Sciences
Department of Pediatrics whereas other results indicate that in immature B cells
BCR ligation results in an extended period of develop-National Jewish Medical and Research Center
and the University of Colorado Health Science Center mental arrest that may eventually lead to cell death, but
is also reversible (Nossal and Pike, 1975; Raff et al.,Denver, Colorado 80206
1975; Sidman and Unanue, 1975; Hartley et al., 1993).
Our in vivo studies using anti±major histocompatibility
complex (MHC) class I Ig-Tg mice (3-83m/d) have shown
Summary that IgM1 immature B cells exposed to autoantigen in
the bone marrow are tolerized by a receptor editing
The ability of BCR cross-linking to stimulate receptor mechanism (Tiegs et al., 1993; Lang et al., 1996), sug-
editing was analyzed in vitro using bone marrow B gesting that negative selection can act at the level of
cells from immunoglobulin (Ig) transgenic (Tg) and the receptor, rather than thecell. However, these studies
non-Tg mice. In cultured Ig-Tg cells, BCR ligation in- analyzed bone marrow in steady state and could not
duced receptor editing as measured by up-regulation address the kinetics of the editing response, nor could
of RAG gene expression, light chain gene DNA re- these studies formally exclude the possibility that self-
arrangements, and expression of l-light chain protein antigen caused selective survival of B cells that contin-
in cells that previously expressed k. In the culture ued to undergo light chain gene rearrangement. In this
conditions used, BCR ligation induced light chain re- paper, we test the hypothesis that short-term in vitro
arrangements in most immature IgM1IgD2 bone mar- exposure of immature bone marrow B cells to BCR li-
row B cells in the absence of significant cell death or gands stimulates receptor editing rather than cell death.
cell growth. Receptor editing in non-Tg B cells was
also documented in cultures treated with anti-immu-
noglobulin. These results provide direct evidence for Results
the ability of BCR ligation to stimulate immunoglobulin
light chain gene rearrangements in immature B cells. BCR Ligation Does Not Accelerate Death
of Immature B Cells
Bone marrow cells from nondeleting (H-2Kd) 3-83m/d Ig-
Introduction Tg mice were cultured in the absence or presence of
saturating levels (10 mg/ml) of anti-idiotypic (Id) mono-
Mouse B cell development occurs in the bone marrow clonal antibody (MAb) 54.1, anti±immunoglobulin k-light
through a quasi-ordered process in which pro-B-cells chain (anti-k) MAb 331812, or isotype-matched control
rearrange immunoglobulin heavy chain genes, proliferate, rat MAb 5Ci, and B cell survival was assessed. At this
and subsequently undergo light chain gene rearrange- antibody concentration, both anti-Id MAband anti-k rap-
ments in theabsence of cell division (reviewed by Rajew- idly down-modulated BCR, while control MAb had no
sky, 1996). Once functional B cell receptor (BCR) is effect (data not shown). Anti-immunoglobulin treatment
expressed on the cell surface, further immunoglobulin did not reduce B cell recovery from Ig-Tg bone marrow
gene rearrangements are inhibited, a process believed cultures 24±72 hr posttreatment (Figure 1A). In addition,
to ensure that each B cell expresses a single BCR (re- as shown in Figure 1B, no differences were observed
viewed by Storb et al., 1994). However, the assembly of in similarly treated cultures of bone marrow cells from
a functional light chain does not always terminate light mice transgenic for both the 3-83 immunoglobulin genes
chain gene rearrangement (Harada and Yamagishi, 1991; and a Bcl-2 construct that directs expression to imma-
Rolink et al., 1993; Prak and Weigert, 1995), and a pro- ture and mature B cells (Nisitani et al., 1993; Strasser
portion of normal surface immunoglobulin1 (sIg1) B cells et al., 1991). Importantly, similar results were obtained in
continue toexpress recombinase mRNA (Ma et al.,1992; non-Tg bone marrow cultures treated with anti-k (Figure
Li et al., 1993). One explanation for these observations 1C), and introduction of the Bcl-2 transgene again had
is that self-antigen binding to the BCR of immature B no effect on this response (Figure 1D). Thus, under these
cellscan stimulate secondary light chain rearrangement, conditions, BCR ligation did not accelerate B cell death.
which has been observed in in vivo studies of immuno-
globulin-transgenic mice (Gay et al., 1993; Tiegs et al.,
1993; Radic et al., 1993; Prak et al., 1994; Lang et al., Antigen Receptor Cross-Linking Rapidly Promotes
Light Chain Gene Recombination1996).
Cross-linking of sIg on immature B cells does not in Immature B Cells
The use of bone marrow B cells from 3-83m/d Tg miceresult in proliferation,as it does in mature B cells (Weiner
et al., 1976), but induces tolerance mechanisms such facilitates the detection of receptor editing because in
these cells RAG expression and endogenous immuno-as anergy, deletion, or receptor editing (reviewed by
Klinman, 1996; Radic and Zouali, 1996). One body of globulin rearrangements are suppressed in the absence
of self-antigen (Tiegs et al., 1993), resulting in a lowdata suggests that immature B cell tolerance is caused
by accelerated cell death (Norvell et al., 1995; Monroe, background over which a BCR ligation-induced signal
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Figure 1. BCR Ligation Does Not Induce
Death of Bone Marrow B Cells
(A and B) Bone marrow cells from 3-83m/d (A)
or 3-83m/d/Bcl-2 (B) mice were cultured either
alone or with 10 mg/ml of anti-Id MAb 54.1,
anti-k MAb 331812, or control MAb 5Ci. The
absolute number of B2201 cells was deter-
mined at various times by counting viable cell
numbers and determining the percentage of
B2201 cells in flow cytometry assays.
(C and D) Bone marrow B cells from B10.D2
(C) or B10.D2/Bcl-2 (D) mice were cultured
as in (A) and (B). Data points represent the
means 6 standard deviation of 2±12 indepen-
dent experiments.
may be visualized. Accordingly, the control and anti- Ig1 bone marrow B cells BCR ligation can induce exten-
sive light chain gene rearrangements.immunoglobulin-treated cultures of Ig-Tg bone marrow
cells described in Figure 1A were analyzed for markers
of receptor editing. As expected, Ig-Tg bone marrow BCR Cross-Linking Induces Expression
of Endogenous Light Chain Proteincells had low levels of RAG-2 mRNA that were unaf-
fected by treatment with control MAb (Figure 2A, lanes As BCR ligationpromoted light chaingene rearrangement,
we predicted that the proportion of treated B cells1 and 2), whereas treatment with either anti-Id or anti-k
stimulated RAG-2 expression (Figure 2A, lanes 3 and expressing endogenous light chain protein should be
detectably increased. As the reagents needed to distin-4). Cross-linking BCR consistently led to a significant
(p , 0.005) 3- to 3.5-fold increase in RAG-2 mRNA levels guish between endogenous and Tg k-light chain pro-
teins were unavailable, we measured l-light chainover several experiments (Figure 2B), a response which
was detectable by 18 hr and peaked by 24 hr (data not expression by flow cytometry, an assay that was capa-
ble of scoring only a small fraction of theB cellsexpress-shown). These results indicated that immature B cells
were capable of either up-regulating or extending the ing endogenous light chains. BCR ligation induced an
increase in the frequency of B cells expressing l-lightduration of RAG-2 gene expression after sIgM1 expres-
sion, and that BCR ligands could induce this response chains (compare [A]±[D] in Figure 4). Approximately 1.5%
of the bone marrow B cells expressed endogenouswithin 1 day.
Under these same culture conditions, BCR ligation l-light chains after BCR ligation, whereas fewer than
0.5% of the B cells expressed l-light chains in the con-also induced light chain gene assembly, as shown by
polymerase chain reaction (PCR) analysis of Vk-Jk1 re- trol cultures after 72 hr (see Figure 4E). This shows that,
in at least a proportion of bone marrow B cells, BCRarrangements (Figure 3). Compared with a standard
curve generated with templates containing known pro- ligation stimulated new rearrangement and expression
of endogenous light chain protein.portions of cells bearing Vk-Jk1 rearrangements (Figure
3A, lanes 1±6), bone marrow cultured for 48 hr in the
absence of BCR stimulus had virtually no endogenous Receptor Editing Can Be Induced in Immature
B Cells from Nontransgenic MiceVk-Jk1 rearrangements (Figure 3A, lanes 8 and 10),
whereas cells treated with anti-Id MAb had abundant The ability of anti-k treatment to induce endogenous
light chain gene expression in 3-83m/d Ig-Tg bone mar-Vk-Jk1 rearrangements (Figure 3A, lanes 9 and 11). By
comparison with a standard curve generated using cell row B cells prompted us to test its effect on normal,
non-Tg cells. Untreated or control MAb±treated bonemixtures with knownamounts of Vk-Jk1 rearrangements
(Figure 3B) and correcting for the fraction of recovered marrow from B10.D2strain mice reproducibly expressed
l-light chains on z6%±7% of the B2201 lymphocytescells that were of the B cell lineage, we estimate that
in treated cultures Vk-Jk1 rearrangements occurred in (Figures 5A and 5B), whereas treatment with anti-k MAb
induced a dose-dependent increase in the percentageabout 48% of the B cells (Figure 3C). This represents
a 37-fold increase over the levels found in control sam- of cells expressing l-light chain (Figures 5C±5E). Cul-
tures treated with 1±100 mg/ml anti-k MAb expressedples, which were estimated to have Vk-Jk1 rearrange-
ments in only 1.3% of the B cells (0.43% of the bone l-light chains on 9%±12% of the lymphocytes, respec-
tively, a statistically significant increase (p , 0.05; Figuremarrow cultures; Figure 3C). These data show that in
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of the responding cells from non-Tg B10.D2 cultures,
we analyzed cultured cells for surface expression of
CD23 and B220. We chose CD23 as a marker of B cell
maturity because its surface expression is not affected
by BCR modulation. Similar to the results seen with the
Tg B cells, we found that in normal bone marrow cultures
the immature B2201/CD232 B cell population had an
increased frequency of l1 cells after treatment (Figure
6B). Thus, in both Tg and non-Tg mouse bone marrow
culture, BCR ligation specifically induced l-light chain
expression on at least a subset of immature B cells.
B Cells Newly Expressing l-Light, Chains Arise
from Preexisting l2 Ig1 Immature B Cells
The increases in l1 B cells induced by BCR ligation
(Figures 4 and 5) could have been the result of either
receptor editing in nonproliferating immature B cells or
the outgrowth of l1 B cells. To distinguish between
these two possibilities, we labeled bone marrow cells
prior to culture with carboxyfluorescein diacetate suc-
cinimidyl ester (CFSE) to track the subsequent prolifera-
tion of the l1 B cells (Lyons and Parish, 1994). With
each cell division, the fluorescence intensity of CFSE
label decreases by half, allowing the visualization of
successive cell divisions (Hodgkin et al., 1996). Figure
6C shows the CFSE labeling profile of B2201 cells in
anti-Id MAb±treated cultures after 72 hr in culture and
shows that the majority of cells had not undergone cell
divisions, while a smaller fraction had undergone one
or two cell divisions. Significantly, none of the l1 B
cells from Ig-Tg cultures had divided during the 72 hrFigure 2. BCR Ligation Increases RAG-2 mRNA Expression in Bone
Marrow B Cells treatment period (Figure 6D), indicating that the l1 B
(A) Reverse transcriptase±polymerase chain reaction (RT±PCR) cells arose from nondividing, l2 immature B cells and
analysis of RAG-2 mRNA expression levels in response to BCR not from the outgrowth of preexisting l1 B cells. Simi-
ligation. Cultures were harvested after 24 hr of treatment. All anti- larly, l1 cells developing in anti-k-treated normal bone
bodies were used at 10 mg/ml final concentration as in Fig-
marrow had also not divided during the culture periodure 1. Control transcript Gas was amplified as a ubiquitously ex-
(Figure 6E). As BCR ligation increased both the percent-pressed gene and used to standardize loading.
age (Figures 4E and 5F) and the absolute number of l1(B) Summary of RT±PCR analysis of RAG-2 mRNA expression levels.
Relative intensity is calculated as RAG-2:Gas ratio of radioactive B cells in the absence of proliferation (Figures 6D and
signal. Bars represent means 6 standard deviation of six indepen- 6E), the increase must have been the result of de novo
dent experiments. Statistical significance determined by JMP 3.15 l expression on cells that already expressed k-chain.
statistical software (SAS Institute, Cary, NC).
Discussion
5F). This increase was also reflected in the absolute
number of l1 cells recovered from the cultures (data Our results demonstrate that sIg cross-linking can rap-
idly initiate secondary light chain gene rearrangementsnot shown). These results indicate that in normal, non-
Tg bone marrow, anti-k treatment can induce the devel- in a large fraction of immature B cells. In Ig-Tg bone
marrow cultures, BCR ligation caused an increase inopment of l1 B cells.
recombinase mRNA by 18 hr of culture, and by 48 hr
substantial Vk-Jk1 rearrangement had occurred. We es-Receptor Editing Occurs in the Immature
B Cell Population timate that the proportion of treated bone marrow B
cells induced to undergo Vk-Jk1 rearrangement was atTo determine which B cell subpopulation was re-
sponding to BCR ligation, we analyzed treated cultures least 24%±48%, depending on whether one or both
k-loci rearranged in each responding cell. This is anby three-color flow cytometry. Bone marrow contains
immature, IgM1/IgD2/CD232 B cells and mature, IgM1/ underestimate of the number of cells undergoing k-light
chain gene rearrangements because Vk-Jk1 rear-IgD1/CD231 B cells (Best et al., 1995; Hardy et al., 1991).
We gated on B2201/IgD1 and B2201/IgD2 B cells from rangements represent only one fourth of the potential
k-light chain gene rearrangements (there are four func-Ig-Tg cultures and analyzed the two populations for
l-light chain expression. As can be seen in Figure 6A, tional Jk subunits) and our Vk primer permits amplifica-
tion of many, but probably not all, Vk-genes. As pre-the immature B2201/IgD2 B cell population contained
the cells newly expressing endogenous l-light chains dicted from in vivo experiments (Tiegs et al., 1993),
immature, IgM1/IgD2/B220low B cells, but not mature Bafter BCR ligation. To determine the stage of maturation
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Figure 3. Induction of Vk-Jk1 Joining after
BCR Ligation in Bone Marrow Cultures
(A) Autoradiograph of samples analyzed by
PCR and Southern blot for endogenous Vk-
Jk1 rearrangements (top panel) and control,
a-actin gene (bottom panel). Cell lysateswere
made after48 hr treatment in culture andused
as template in PCR assays for rearrangement
products. Lanes 1±6 show results for control
lysates madewith mixturesof various propor-
tions of VkJk1-positive and VkJk1-negative
hybridoma cell lines. Lanes 8 and 10 show
PCR results from untreated cultures of
3-83m/d and 3-83m/d/Bcl-2 bone marrow, re-
spectively. Lanes 9 and 11 show results from
the anti-Id MAb 54.1 (10 mg/ml) treated cul-
tures of 3-83m/d and 3-83m/d/Bcl-2 bone mar-
row, respectively.
(B) Standard curve derived from (A) relating
the band intensity to fraction of cells bearing
a Vk-Jk1 rearrangement.
(C) Estimated fraction of control and anti-Id-
treated B cells that bear Vk-Jk1 rearrange-
ment after 48 hr of treatment. Data shown are
the means of six independent experiments 6
the standard deviation.
cells, were able to respond to BCR ligation by receptor editing in two possible ways (see Figure 7). Pre-B-cells
that productively rearrange light chains express sIgMediting.
In cultures of normal bone marrow, the cells re- and therefore may transiently coexpress both RAG
mRNA and sIgM. Cells with this phenotype have beensponding to BCR ligation were nondividing, IgM1/
CD232/B220low immature B cells. As assessed by three- detected by several laboratories (Li et al., 1993; Ma et
al., 1992; Tiegs et al., 1993). A selection event, which iscolor flow cytometry, 40%of theB2201 cells were sIgM1
after 48 hr in culture, and 20%±30% of the sIgM1 B not clearly understood, is necessary for the immature
B cell to progress in B cell development to a IgM1/IgD2/cells had an immature phenotype, consistent with other
published data (Hardy et al., 1991). If we consider only RAG2 phenotype, which in turn matures to a IgM1/IgD1/
RAG2 phenotype and migrates into the periphery. Anti-the immature B cells, l-light chain expression increased
from a background of z20% of the B cells in control gen or self-reactivity could either cause the immature
RAG2 B cell to reinitiate light chain gene recombinationcultures up to z65% in anti-k-treated cultures, indicat-
ing that z45% of the immature B cells underwent recep- (pathway 1) or could block the development of the imma-
ture B cell at the RAG1 stage, preventing the terminationtor editing and successfully rearranged a l-light chain in
response to BCR ligation. Since l-light chain expression of V(D)J recombination (pathway 2). Although our results
are consistentwith both possibilities, others have showndoes not identify cells that have attempted but failed
l-light chain rearrangements, or cells that attempted that sIg cross-linking can up-regulate RAG expression
in a human B cell lymphoma (Verkoczy et al., 1995).k-light chain rearrangements, a conservative estimate
is that in response to BCR ligation .45% of the imma- Further experiments are needed to distinguish between
these possibilities.ture, Igk1 B cells from the normal mice attempted recep-
tor editing. One potential reason we failed to detect The sensitivity of bone marrow B cells to antigen-
induced tolerance has been documented in other in vitroeven higher levels of l-light chain expression after BCR
ligation in immature bone marrow B cells is that l re- systems(Nossal and Pike, 1975; Raff et al., 1975; Sidman
and Unanue, 1975) and has been attributed to acceler-arrangements occur relatively late after commitment to
light chain gene rearrangements (Arakawa et al., 1995) ated cell death (Norvell et al., 1995), yet immature bone
marrow B cellsdo not dieafter BCR ligation in our cultureand k-light chains, which are rearranged earlier than
l-light chains, may initially be favored over l-light chains system even with high concentrations of MAb (Figure
1; data not shown). These discrepancies may be attrib-in receptor editing. Nonetheless, these results, along
with the observation that BCR ligation induced Vk-Jk1 uted to differences in culture conditions, the reagents
used for BCR cross-linking, or, in the case of Norvell etrearrangement in a large fraction of cells, indicate that
most immature bone marrow B cells can undergo recep- al. (1995), to the effects of affinity isolation of immature
B cells on anti-immunoglobulin-coated dishes. Whiletor editing after BCR ligation.
We propose that BCR ligation could promote receptor we used anti-immunoglobulin light chain MAb in these
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MAb did not diminish B cell survival, but enhanced re-
ceptor editing as indicated both by the increases in the
percentage of l1 B cells (Figure 5) and the absolute
number of l1 B cells (data not shown). We believe that
the bone marrow environment necessary for immature
B cell survival is maintained in our culture system and
that the absence of these unknown environmental fac-
tors in the purified immature B cells used by Norvell et
al. promotes or primes apoptosis that can be further
accelerated by BCR cross-linking.
This study suggests that receptor editing, rather than
accelerated cell death, may be the dominant tolerance
mechanism of immature bone marrow B cells. If true,
this represents a major paradigm shift, as it indicates
that ªreceptor selectionº rather than ªclonal selectionº
is the major mechanism of B cell immune tolerance.
Unlike clonal elimination by cell death, receptor editing
effectively uncouples the fate of the autoreactive B cell
from that of its receptor. While this study shows that
receptor editing can occur efficiently in bone marrow B
cells, it does not address the question of whether or not
this mechanism is common under normal circum-
stances. The proportion of bone marrow B cells that
normally undergo receptor editing and tolerance induc-
tion is not known, but is predicted from theoretical mod-
els to be high (Nemazee, 1996). The surprisingly poor
allelic exclusion mediated by germline targeted func-
tional light chain genes (Prak and Weigert, 1995) and
recent analysis of molecular footprints of receptor edit-
ing in normal B cells (M. Retter and D. N., unpublished
data) are consistent with this interpretation.
Experimental Procedures
Mice and Cell Lines
Figure 4. BCR Ligation Increases the Proportion of Immature B 3-83m/d transgenic mice (Russell et al., 1991) were maintained on
Cells Expressing (Endogenous) l-Light Chain an autoantigen-free, nondeleting (H-2Kd) background. Experimental
mice were generated by breeding homozygous 3-83m/d transgenic(A±D) Flow cytometric analysis of bone marrow cultures 72 hr after
males with B10.D2 (Jackson Laboratories, Bar Harbor, ME) femalesno treatment (A) or treatment with either 10 mg/ml control MAb 5Ci
or B10.D2/Bcl-2 females (Strasser et al., 1991). All mice were bred(B), anti-Id MAb 54.1 (C), or anti-k 331812 (D). Bone marrow cells
and maintained in the animal care barrier facility at the National(2 3 106) were stained with anti-B220-PE and anti-l-FITC and ana-
Jewish Center for Immunology and Respiratory Medicine. Bone mar-lyzed on a FacsCalibur flow cytometer.
row was isolated from mice at 6±8 weeks of age.(E) The effect of BCR ligation on the percentage of B cells that
Nonsecreting mouse myeloma P3x63-Ag8.653 was obtained fromexpress endogenous l-light chains after 72 hr in culture. Data repre-
the American Type Tissue Culture Collection (Rockville, MD). VJk1-sent the means 6 standard deviation of ten independent experi-
bearing hybridoma 36-65 was obtained from Dr. Lawrence Wysocki.ments.
Cells were maintained in IMDM as described below.
Culture Conditionsstudies, Norvell et al. found that much higher concen-
Bone marrow cells were prepared as described (Tiegs et al., 1993).trations of polyclonal antibodies directed against the
Femurs were removed asceptically from 6- to 8-week-old mice,
entire BCR complex (anti-IgM) were required to induce ground in a mortar containing 10 ml of ice-cold sterile HBSS (Gibco
apoptosis in purified immature B cell preparations. It is Laboratories, Grand Island, NY), and filtered through sterile cotton
to remove bone fragments. Red blood cells were lysedwith bufferedpossible that the nature of the signal delivered through
ammonium chloride. Bone marrow cells were placed in 6-well tissuethe BCR may be important and that higher order BCR
culture plates at 10 3 106 cells per milliliter in IMDM (Gibco) supple-cross-linking may favor death over editing. However,
mented with 10% fetal calf serum, 1% sodium pyruvate, 100 U/mlthe multivalent cell surface MHC antigens do not appear
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, and 50 mM
to deplete reactive bone marrow B cells in vivo (Tiegs 2-b-mercaptoethanol and maintained at 378C with 7% CO2. MAbs
et al., 1993; Lang et al., 1996). Apoptotic cells may be in PBS (2±5 mg/ml stocks) were added to a final concentration of
10 mg/ml.difficult to detect in our culture system as they are most
likely engulfed by phagocytic cells relatively quickly.
CFSE LabelingHowever, cultures from Bcl-2-Tg bone marrow did not
Cells treated with CFSE (Molecular Probes, Eugene, OR) were la-reveal any increases in B cell numbers in vitro (Figure
beled as described (Hodgkin et al., 1996). In brief, a stock solution
1), and the Bcl-2 transgene does not block central toler- of 5 mM CFSE in DMSO was diluted 1:10 in serum-free IMDM pre-
ance or receptor editing in vivo (J. Lang and D. N., un- warmed to 378C. Bone marrow cells were diluted to 50 3 106 cells
per milliliter and incubated with 10 ml of diluted CFSE per milliliterpublished data). Furthermore, higher concentrations of
Immunity
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Figure 5. BCR Ligation Enhances Receptor
Editing in Immature B Cells from Normal,
Nontransgenic Mice
(A±E) Flow cytometric analysis of k- and
l-light chain surface expression in B2201
gated bone marrow cells from B10.D2 mice
after 48 hr of treatment in culture. Cells were
stimulated with no added antibody (A), 100
mg/ml control MAb 54.1 (B; this anti-3-83-Id
MAb does not bind to normal, non-Tg B cells),
1 mg/ml anti-k MAb (C), 10 mg/ml anti-k MAb
(D), or 100 mg/ml anti-k MAb (E). The extreme
down-modulation of k-light chain expression
in (D) and (E) is not associated with cell death,
but is the result of receptor down-modulation
and epitope blocking by the treatment an-
tibody.
(F) Percentages of B cells expressing l-light
chain in B10.D2 bone marrow cultures after
48 hr. Percentages represent the means 6
standard deviation of six to nine independent
experiments. Asterisk indicates a statistical
significance of p , 0.05 determined by JMP
3.15 statistical software.
Figure 6. B Cell Maturation Stage and CFSE
Analysis of Cell Division of l1 Cells in Treated
and Control Cultures
(A) Absolute number of l1 B cells in immature
IgD2 and mature IgD1 B cell subpopulations
in Ig-Tg bone marrow cultures. l1 cell counts
were determined from IgD1B2201 or IgD2
B2201 cells from Ig-Tg bone marrow cultures
after 48 hr in untreated culture, or cultures
treated with 10 mg/ml control MAb or anti-Id
MAb.
(B) Absolute number of l1 B cells in immature
CD232 and mature CD231 B cell subpopula-
tions in normal bone marrow cultures. l1 cell
counts were determined from CD231B2201
or CD232B2201 cells from normal B10.D2
bone marrow cultures after 48 hr in untreated
culture, or cultures treated with 10 mg/ml con-
trol MAb or anti-k MAb.
(C) Histogram of total CFSE-labeled B2201
cells. Peaks of CFSE fluorescence intensity
represent successive cell division; with each
division the cells lose approximately half of
the FL1 mean fluorescence. Broken vertical
lines mark 0, 1, and 2 cell divisions.
(D) Histogram of CFSE labeling in gated l1
cells from Ig-Tg bone marrow cultures 48 hr
after no treatment or treatment with 10 mg/
ml anti-Id MAb. Histograms are overlaid and
show that few l1 cells have undergone cell
divisions.
(E) Histogram of CFSE labeling in gated l1
cells from normal bone marrow. Cells were
gated on l1 lymphocytes as in (D) and show
overlaid histograms of cultures either un-
treated or treated with 10 mg/ml control MAb
or 10 mg/ml anti-k MAb.
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min at 48C, RNA pellets were washed once with 70% ethanol and
resuspended in sterile H2O. First strand cDNA synthesis, Gas and
RAG-2 PCR amplifications, Southern blot transfers, and detection
were performed as previously described (Tiegs et al., 1993).
Rearrangement PCR Assay
To generate DNA-containing templates for PCR, bone marrow cells
were incubated in lysate buffer (10 mM Tris [pH 8.4], 50 mM KCl,
0.45% [v/v] Tween-20, 0.45% [v/v] NP-40, 0.1 mg/ml gelatin, and
4% [v/v] proteinase K of a 10 mg/ml stock) at 558C overnight. Tem-
plates were denatured for 2 min at 948C and amplified for 26 cycles
consisting of a denaturation step at 948C for 30 s, an annealing step
at 588C for 1 min, and an extension at 728C for 1.5 min. Vk-Jk1
rearrangements were detected by PCR amplification using the fol-
lowing primers: sense Vk primer (Schlissel primer), 59- GGCTGCAG/Figure 7. Two Ways That BCR Ligation Could Promote Receptor
(GC)TTCAGTGGCAGTGG/(AG)TC/(AT)-39, and anti-sense Jk1 IVSEditing
primer, 59-GCCACAGACATAGACAACGGAAGAA-39. PCR reactions
This schematic depicts a model of immature B cell development. were performed in a 30 ml final volume containing 2.4 ml of 2.5 mM
The cell depicted at the left is the immediate descendant of a pre- (each) dNTP, 3 ml of sense and 3 ml of anti-sense primers (10 mM),
B-cell that actively rearranged light chain genes and was able to 3 ml of 103 PCR buffer (100 mM Tris±HCl [pH 8.4], 500 mM KCl, 20
form a functional light chain. This cell may transiently continue to mM MgCl2, 1% Triton X-100, and 0.1 mg/ml gelatin), 0.2 ml of Taq
express the recombination machinery and ªtestº its antigen receptor enzyme (Perkin-Elmer Corporation, Norwalk, CT), and 1 ml of tem-
on the cell surface. In the absence of tolerogen, further maturation plate. a-Actin amplification was carried out using the same PCR
terminates light chain recombination (represented by the cell in conditions and the following primers: sense actin primer, 59-GGT
the center marked ªrecombination2ª) and allows further maturation, GTCATGGTAGGTATGGGT-39, and anti-sense actin primer, 59-CGC
ultimately allowing export to the periphery (represented by the cell ACAATCTCACGTTCAG-39 (Hardy et al., 1991). PCR products were
marked ªmature Bº at right). Antigen may cause an immature B resolved on 1% TAE agarose gels and transferred to Zetaprobe
cell that has stopped expressing the recombination machinery to membranes and probed with Jk1 or a-actin probes, as described
reexpress it and to undergo secondary light chain rearrangements (Tiegs et al., 1993).
(pathway 1). Alternatively, antigen may block the developmental
progression of immature B cells that express the recombination
Acknowledgmentsmachinery (pathway 2). In either case, antigen would cause imma-
ture B cells to express the recombination machinery and to initiate
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